• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Med Oral Patol Oral Cir Bucal . Evaluation of the xerostomia, taste and smell impairments after Covid-19

tetano

Editor, Senior Moderator
Med Oral Patol Oral Cir Bucal


. 2021 Mar 27;24510.
doi: 10.4317/medoral.24510. Online ahead of print.
Evaluation of the xerostomia, taste and smell impairments after Covid-19


M-M Omezli[SUP] 1 [/SUP], D Torul



Affiliations
Free article

Abstract

Background: The purpose of this study was to explore the effects of coronavirus disease 19 (Covid-19) on the oral cavity by evaluating the oral findings in the patients who recovered after treatment.
Material and methods: This study involved confirmed Covid-19 patients whose treatment completed at least two weeks ago. A questionnaire consist of eight parts was applied to explore the oral findings after Covid-19. Also stimulated salivary flow rate was evaluated with a salivary flow test.
Results: 177 patients reached and 107 of them participate in the study. Regarding gender significant differences were found in terms of the presence of taste impairment after treatment (p=0.007), the degree of taste (p=0.021) and smell (p=0.010) impairment. 18 % (5/27) of the patients evaluated were showed hyposalivation. No significant differences were observed regarding salivary flow between males (mean?SD: 1.14?0.65) and females (mean?SD: 1.12?0.43), (p=0.928); among the patients having treatment at home (mean?SD: 1.03?0.48) or hospital (mean?SD: 1.33?0.65), (p=0.187). In some of the patients' taste [15], smell [23] impairment, and xerostomia [43] still observed at least two weeks after the treatment is completed.
Conclusions: The most frequent finding in patients after the treatment was xerostomia. Taste and smell impairments were more frequently observed in females.
 
Back
Top Bottom